Welcome to the latest edition of NORML’s Weekly Legislative Roundup! This week, U.S. Senator Ron Wyden and Congressman Earl Blumenauer introduced legislation to allow for interstate commerce when it comes to state-legal cannabis programs. Governor Janet Mills (D) of Maine signed legislation into law setting rules and regulations for the adult use cannabis market. Governor […]

Welcome to the latest edition of NORML’s Weekly Legislative Roundup! This week, the U.S. Drug Enforcement Administration placed CBD medication Epidiolex in Schedule V, the least restrictive category of the Controlled Substances Act. The move does not apply to CBD itself or other non-FDA-approved extracts containing it. U.S. Customs and Border Protection released an official […]

Welcome to the latest edition of NORML’s Weekly Legislative Roundup! This week, reports circulated that the US Customs and Border Protection Agency will enforce a federal policy denying entry into the United States any individual involved in Canada’s burgeoning marijuana market. Under the policy, US officials are to bar entry to Canadians who acknowledge having […]

Welcome to the latest edition of NORML’s Weekly Legislative Roundup! The U.S. House Judiciary Committee approved legislation (HR 5634: The Medical Cannabis Research Act of 2018) to facilitate federally-approved clinical trials assessing the efficacy of whole-plant cannabis. The vote marks the first time that lawmakers have ever decided in favor of easing existing federal restrictions […]